Design and performance assessment of continuous crystallization processes resolving racemic conglomerates

dc.contributor.authorKöllges, Till
dc.contributor.authorVetter, Thomas
dc.date.accessioned2026-03-30T11:16:59Z
dc.date.issued2018-02-12
dc.description.abstractContinuous crystallization processes achieving the complete resolution of racemic feed mixtures of conglomerate forming substances are presented. The processes considered rely on the principles of preferential crystallization or attrition-enhanced deracemization (Viedma ripening). A single mechanistic population balance model is shown to describe both operating modes. For the case of isothermal Viedma ripening, a shortcut method is introduced that allows the rapid and computationally efficient design of processes using a single or multiple ripening stages. The achievable productivity and enantiomeric purity are determined for all process variants in a wide range of operating conditions, and Pareto optimal operating points are identified. Since our results are obtained with a consistent set of kinetics for all operating modes, an unbiased comparison is enabled. It is shown that the productivity of the ripening process can be improved by using cascades of multiple crystallizers, but that the preferential crystallization process still achieves higher productivity at full enantiomeric purity.
dc.identifier.doi10.1021/acs.cgd.7b01618
dc.identifier.issn1528-7483
dc.identifier.issn1528-7505
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/56131
dc.issue3
dc.language.isoen
dc.publisherAmerican Chemical Society
dc.relation.ispartofCrystal Growth & Design
dc.subjectCrystallization
dc.subjectMolecular structure
dc.subjectRipening
dc.subjectSeparation science
dc.subjectSuspensions
dc.subject.ddc500 - Naturwissenschaften
dc.titleDesign and performance assessment of continuous crystallization processes resolving racemic conglomerates
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume18
dspace.entity.typePublication
fhnw.InventedHereNo
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publication
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharmatechnologie und Biotechnologiede_CH
fhnw.oastatus.auroraVersion: Accepted *** Embargo: 12 months *** Licence: None *** URL: https://v2.sherpa.ac.uk/id/publication/7772
fhnw.openAccessCategoryClosed
fhnw.publicationStatePublished
relation.isAuthorOfPublication8334deb0-d1e5-410e-a54a-43d82d4dc525
relation.isAuthorOfPublication.latestForDiscovery8334deb0-d1e5-410e-a54a-43d82d4dc525
Dateien

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
license.txt
Größe:
2.66 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: